+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Cell and Gene Therapy Contract Development and Manufacturing Organization Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type, Product Type, End User, and Geography

  • PDF Icon

    Report

  • 249 Pages
  • June 2025
  • Region: Global
  • The Insight Partners
  • ID: 6102992
According to our new research study on “Cell and Gene Therapy Contract Development and Manufacturing Organization Market Forecast to 2031 -Global Analysis - by Service Type, Product Type, End User, and Geography,” the market is anticipated to grow from US$ 6.22 billion in 2024 and is projected to reach US$ 31.86 billion by 2031; it is expected to register a CAGR of 26.4% during 2025-2031.

Increasing clinical trials for innovative therapies and surging regulatory approvals and commercialization are contributing to the growing cell and gene therapy contract development and manufacturing organization market size. However, the high manufacturing complexities hampers the cell and gene therapy contract development and manufacturing organization market growth. Further, rising integration of AI and digital transformation is expected to bring in new cell and gene therapy contract development and manufacturing organization market trends in the coming years.

In terms of revenue, North America dominated the market in 2024. It is estimated to dominate the global market during the forecast period. The US is the largest market for cell and gene therapy contract development and manufacturing organization in the world. The US is observing growing advancements in biotechnology, an increasing prevalence of genetic diseases, and surging demand for specialized manufacturing services. As per the estimates of the US Government Accountability Office published in October 2021, ~25 to 30 million people suffer from rare diseases in the country.

As per the Food and Drug Administration (FDA), more than 7,000 rare diseases affect over 30 million people in the country. The growing understanding of these diseases has led to a surge in gene therapy development. CDMOs play a crucial role in this space by providing specialized services for the development and manufacturing of gene therapies targeting rare genetic disorders.

In 2023, the US FDA approved numerous cell and gene therapies, including gene-editing treatments targeting rare diseases. Therapies such as exagamglogene autotemcel (Casgevy) and lovotibeglogene autotemcel for sickle cell disease, as well as valoctocogene roxaparvovec for severe hemophilia A, have received FDA approval, highlighting the potential of gene therapies in addressing rare disease challenges. The accelerated regulatory pathways, such as the Regenerative Medicine Advanced Therapy (RMAT) designation, have spurred biotechnology companies to partner with CDMOs for scaling production.
Investments in manufacturing infrastructure have bolstered the market growth. The National Cell Manufacturing Consortium, established through collaboration between 15 academic institutes, over 25 companies, and government agencies, aims to enable cost-effective, large-scale manufacturing of cell therapies. In addition, strategic collaborations between CDMOs, academic institutions, and biopharma companies also contribute to market growth.

Cell and Gene Therapy Contract Development and Manufacturing Organization Market Analysis
Access to Specialized Facilities and Technologies to Provide Market Opportunities in Future
The demand for cell and gene therapies is driving biopharmaceutical companies toward CDMOs that can provide cutting-edge facilities and technologies, which are required to scale up production while ensuring quality, compliance, and regulatory approval. These specialized capabilities are essential for the production of complex and personalized therapies, which require advanced infrastructure to maintain high manufacturing standards. Cell and gene therapies, including gene editing, viral vector production, and personalized medicine, require specialized facilities equipped with the latest technologies.

The production of viral vectors used in gene therapies requires GMP standard facilities to ensure the safety, consistency, and quality of the final product. These facilities should be equipped to handle complex biological materials, such as live cells and genetically modified organisms, in controlled and monitored environments. The increasing adoption of automated cell culture systems, continuous manufacturing, and digital quality monitoring systems enhances the growth and efficiency of gene therapy production. For instance, in March 2025, Bharat Biotech invested US$ 75 million in its first cell and gene therapy facility in the southern India which is expected to launch new therapies in next 3 years for oncology and rare disease.

The need for specialized facilities creates a substantial opportunity for CDMOs. It is cost-effective and efficient for biopharma companies to collaborate with CDMOs that have the required technology and facilities. For instance, in 2023, Bristol-Myers Squibb collaborated with a CDMO for the production of its CAR-T cell therapy, Breyanzi. This therapy involves harvesting, modifying, and expanding a patient’s T-cells, a process requiring specialized technology and facilities to ensure the desired therapeutic effect.

By leveraging CDMO expertise in specialized facilities, Bristol-Myers Squibb was able to scale production while ensuring regulatory compliance and quality. Thus, the soaring need for advanced manufacturing capabilities with advanced technology is expected to create future growth opportunities for the cell and gene therapy contract research and development organization market.

Cell and Gene Therapy Contract Development and Manufacturing Organization Market Report Segmentation Analysis
Key segments that contributed to the derivation of the cell and gene therapy contract development and manufacturing organization market analysis are service type, product type, and end user.
  • Based on service type, the cell and gene therapy contract development and manufacturing organization market is segmented into drug development and manufacturing, testing and regulatory services, and others. The drug development and manufacturing segment held the largest share of the market in 2024.
  • In terms of product type, the cell and gene therapy contract development and manufacturing organization market is bifurcated into gene therapy and cell therapy. The cell therapy segment dominated the market in 2024.
  • By end user, the cell and gene therapy contract development and manufacturing organization market is categorized into pharmaceutical companies, biopharmaceutical companies, and others. The biopharmaceutical companies segment dominated the market in 2024.
Cell and Gene Therapy Contract Development and Manufacturing Organization Market: Competitive Landscape and Key Developments
WuXi Biologics Inc, Charles River Laboratories International Inc, Catalent Inc, Lonza Group AG, Thermo Fisher Scientific Inc., AGC Biologics AS, Takara Bio Inc, FUJIFILM Holdings Corp, Pluri Inc, SK pharmteco Inc, Aenova Holding GmbH, and Minaris Advanced Therapies are among the key companies operating in the cell and gene therapy contract development and manufacturing organization market.

Statistics Canada, World Population Prospectus, Globocan, Brazilian Health Regulatory Agency (ANVISA), Alliance for Regenerative Medicine (ARM), and the Food and Drug Administration (FDA) are among the primary and secondary sources referred to while preparing the cell and gene therapy contract development and manufacturing organization market report.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the cell and gene therapy contract development and manufacturing organization market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the cell and gene therapy contract development and manufacturing organization market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Analyst Market Outlook
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Landscape
4.1 Overview
4.2 Global Plasmid Manufacturing Market
5. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Key Market Dynamics
5.1 Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Clinical Trials for Innovative Therapies
5.2.2 Surging Regulatory Approvals and Commercialization
5.3 Market Restraints
5.3.1 High Manufacturing Complexities
5.4 Market Opportunities
5.4.1 Access to Specialized Facilities and Technologies
5.5 Future Trends
5.5.1 Rising Integration of AI and Digital Transformation
5.6 Impact of Drivers and Restraints:
6. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Global Market Analysis
6.1 Cell And Gene Therapy Contract Development and Manufacturing Organization Market Revenue (US$ Million), 2021-2031
6.2 Cell And Gene Therapy Contract Development and Manufacturing Organization Market Forecast Analysis
7. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Analysis - by Service Type
7.1 Drug Development and Manufacturing
7.1.1 Overview
7.1.2 Drug Development and Manufacturing: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Testing and Regulatory Services
7.2.1 Overview
7.2.2 Testing and Regulatory Services: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Others
7.3.1 Overview
7.3.2 Others: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
8. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Analysis - by Product Type
8.1 Gene Therapy
8.1.1 Overview
8.1.2 Gene Therapy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Cell Therapy
8.2.1 Overview
8.2.2 Cell Therapy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
9. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Analysis - by End User
9.1 Pharmaceutical Companies
9.1.1 Overview
9.1.2 Pharmaceutical Companies: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Biopharmaceutical Companies
9.2.1 Overview
9.2.2 Biopharmaceutical Companies: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
10. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Geographical Analysis
10.1 Overview
10.2 North America
10.2.1 North America Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
10.2.2 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.2.2.1 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
10.2.2.2 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
10.2.2.3 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
10.2.3 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
10.2.3.1 North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
10.2.3.2 United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.2.3.2.1 United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.2.3.2.2 United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.2.3.2.3 United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.2.3.3 Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.2.3.3.1 Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.2.3.3.2 Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.2.3.3.3 Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.2.3.4 Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.2.3.4.1 Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.2.3.4.2 Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.2.3.4.3 Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.3 Europe
10.3.1 Europe Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
10.3.2 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.3.2.1 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
10.3.2.2 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
10.3.2.3 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
10.3.3 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
10.3.3.1 Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
10.3.3.2 Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.3.3.2.1 Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.3.3.2.2 Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.3.3.2.3 Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.3.3.3 United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.3.3.3.1 United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.3.3.3.2 United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.3.3.3.3 United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.3.3.4 France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.3.3.4.1 France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.3.3.4.2 France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.3.3.4.3 France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.3.3.5 Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.3.3.5.1 Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.3.3.5.2 Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.3.3.5.3 Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.3.3.6 Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.3.3.6.1 Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.3.3.6.2 Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.3.3.6.3 Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.3.3.7 Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.3.3.7.1 Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.3.3.7.2 Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.3.3.7.3 Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.4 Asia Pacific
10.4.1 Asia Pacific Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
10.4.2 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.4.2.1 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
10.4.2.2 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
10.4.2.3 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
10.4.3 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
10.4.3.1 Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
10.4.3.2 China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.4.3.2.1 China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.4.3.2.2 China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.4.3.2.3 China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.4.3.3 Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.4.3.3.1 Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.4.3.3.2 Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.4.3.3.3 Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.4.3.4 India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.4.3.4.1 India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.4.3.4.2 India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.4.3.4.3 India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.4.3.5 Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.4.3.5.1 Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.4.3.5.2 Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.4.3.5.3 Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.4.3.6 South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.4.3.6.1 South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.4.3.6.2 South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.4.3.6.3 South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.4.3.7 Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.4.3.7.1 Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.4.3.7.2 Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.4.3.7.3 Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.5 Middle East and Africa
10.5.1 Middle East and Africa Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
10.5.2 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.5.2.1 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
10.5.2.2 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
10.5.2.3 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
10.5.3 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
10.5.3.1 Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
10.5.3.2 Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.5.3.2.1 Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.5.3.2.2 Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.5.3.2.3 Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.5.3.3 South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.5.3.3.1 South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.5.3.3.2 South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.5.3.3.3 South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.5.3.4 United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.5.3.4.1 United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.5.3.4.2 United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.5.3.4.3 United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.5.3.5 Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.5.3.5.1 Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.5.3.5.2 Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.5.3.5.3 Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.6 South and Central America
10.6.1 South and Central America Cell And Gene Therapy Contract Development and Manufacturing Organization Market Overview
10.6.2 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.6.2.1 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Service Type
10.6.2.2 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Product Type
10.6.2.3 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by End User
10.6.2.4 South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast Analysis - by Country
10.6.2.5 Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.6.2.5.1 Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.6.2.5.2 Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.6.2.5.3 Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.6.2.6 Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.6.2.6.1 Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.6.2.6.2 Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.6.2.6.3 Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
10.6.2.7 Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
10.6.2.7.1 Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Service Type
10.6.2.7.2 Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Product Type
10.6.2.7.3 Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by End User
11. Competitive Landscape
11.1 Global Company Market Share Analysis, 2024
12. Industry Landscape
12.1 Overview
12.2 Expansion
12.3 New Product Development
12.4 Merger and Acquisition
12.5 Partnerships
12.6 Other Business Strategies
13. Company Profiles
13.1 WuXi Biologics Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Charles River Laboratories International Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Catalent Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Lonza Group AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Thermo Fisher Scientific Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 AGC Biologics AS
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Takara Bio Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 FUJIFILM Holdings Corp
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Pluri Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 SK pharmteco Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Aenova Holding GmbH
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Minaris Advanced Therapies
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
14. Appendix
14.1 Glossary of Terms
14.2 About the Publisher
List of Tables
Table 1. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Segmentation
Table 2. Global Plasmid Manufacturing Market, US$ Million, 2021-2031
Table 3. Global Plasmid Manufacturing Market, By Type, 2021-2031 (US$ Million)
Table 4. Global Plasmid Manufacturing Market, By Application, 2021-2031 (US$ Million)
Table 5. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million)
Table 6. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million)
Table 7. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 8. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 9. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 10. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 11. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 12. Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 13. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
Table 14. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 15. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
Table 16. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 17. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
Table 18. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 19. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
Table 20. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
Table 21. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 22. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 23. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 24. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 25. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 26. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 27. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 28. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 29. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 30. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 31. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 32. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 33. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 34. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 35. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 36. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 37. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 38. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 39. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
Table 40. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 41. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
Table 42. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 43. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
Table 44. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 45. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
Table 46. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
Table 47. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 48. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 49. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 50. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 51. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 52. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 53. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 54. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 55. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 56. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 57. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 58. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 59. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 60. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 61. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 62. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 63. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 64. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 65. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 66. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 67. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 68. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 69. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 70. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 71. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 72. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 73. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 74. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 75. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 76. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 77. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 78. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 79. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 80. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 81. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 82. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 83. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
Table 84. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 85. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
Table 86. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 87. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
Table 88. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 89. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
Table 90. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
Table 91. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 92. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 93. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 94. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 95. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 96. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 97. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 98. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 99. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 100. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 101. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 102. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 103. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 104. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 105. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 106. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 107. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 108. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 109. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 110. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 111. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 112. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 113. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 114. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 115. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 116. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 117. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 118. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 119. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 120. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 121. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 122. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 123. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 124. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 125. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 126. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 127. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
Table 128. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 129. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
Table 130. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 131. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
Table 132. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 133. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
Table 134. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
Table 135. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 136. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 137. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 138. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 139. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 140. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 141. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 142. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 143. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 144. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 145. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 146. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 147. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 148. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 149. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 150. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 151. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 152. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 153. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 154. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 155. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 156. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 157. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 158. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 159. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Service Type
Table 160. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 161. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Product Type
Table 162. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 163. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by End User
Table 164. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 165. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024 (US$ Million) - by Country
Table 166. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Country
Table 167. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 168. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 169. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 170. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 171. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 172. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 173. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 174. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 175. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 176. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 177. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 178. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
Table 179. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Service Type
Table 180. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Service Type
Table 181. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by Product Type
Table 182. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by Product Type
Table 183. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2024(US$ Million) - by End User
Table 184. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2025 - 2031 (US$ Million) - by End User
List of Figures
Figure 1. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Revenue (US$ Million), 2021-2031
Figure 5. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Share (%) - by Service Type (2024 and 2031)
Figure 6. Drug Development and Manufacturing: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
Figure 7. Testing and Regulatory Services: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Others: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Share (%) - by Product Type (2024 and 2031)
Figure 10. Gene Therapy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Cell Therapy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Share (%) - by End User (2024 and 2031)
Figure 13. Pharmaceutical Companies: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Biopharmaceutical Companies: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown by Region, 2024 and 2031 (%)
Figure 17. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 18. North America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 19. United States: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 20. Canada: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 21. Mexico: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 22. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 23. Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 24. Germany: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 25. United Kingdom: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 26. France: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 27. Spain: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 28. Italy: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 29. Rest of Europe: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 30. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 31. Asia Pacific: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 32. China: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 33. Japan: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 34. India: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 35. Australia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 36. South Korea: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 37. Rest of APAC: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 38. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 39. Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 40. Saudi Arabia: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 41. South Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 42. United Arab Emirates: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 43. Rest of Middle East and Africa: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 44. South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 45. Brazil: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 46. Argentina: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 47. Rest of South and Central America: Cell And Gene Therapy Contract Development and Manufacturing Organization Market - Revenue, 2021 - 2031 (US$ Million)
Figure 48. Global Company Market Share Analysis, 2024

Companies Mentioned

Some of the leading companies in the Cell and Gene Therapy Contract Development and Manufacturing Organization Market include:
  • WuXi Biologics Inc
  • Charles River Laboratories International Inc
  • Catalent Inc
  • Lonza Group AG
  • Thermo Fisher Scientific Inc.
  • AGC Biologics AS
  • Takara Bio Inc
  • FUJIFILM Holdings Corp
  • Pluri Inc
  • SK pharmteco Inc
  • Aenova Holding GmbH
  • Minaris Advanced Therapies

Table Information